Price (delayed)
$13.51
Market cap
$159.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.86
Enterprise value
$142.24M
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically
There are no recent dividends present for LNSR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.